MWIQ; AI-powered decision support tool for diabetes clinicians
Research type
Research Study
Full title
MyWay IQ (MWIQ); safety and efficacy testing of a diagnosis and precision medicine tool for diabetes management.
IRAS ID
305267
Contact name
Debbie Wake
Contact email
Sponsor organisation
MyWay Digital Health Ltd
ISRCTN Number
ISRCTN17422256
Duration of Study in the UK
0 years, 5 months, 31 days
Research summary
Diabetes is a growing problem in our society. Early effective management prevents complications. Despite this, outcomes for people with diabetes are poor. The use of clinician-focused computer decision-support could transform care. MyWayIQ (MWIQ) is an artificial intelligence (AI) powered decision-support software device that predicts diabetes type, patient response to treatment and risk of complications. It provides Health Care Professionals (HCPs) with alerts/notifications via a dashboard on their computer providing support for clinical decision making. This investigation will determine whether MWIQ is safe, usable, alters HCP behaviour and leads to any changes in clinical outcomes for patients under the care of HCPs using the tool.
This investigation aims to test MWIQ within 8 general practices and a community diabetes clinic within Greater Manchester. Up to 16 HCPs involved in the care of people with diabetes will be invited to use MWIQ within diabetes clinics over a period of 6-9 months. Feedback will be sought via online interviews and questionnaires. Investigators will also analyse how the computer was used by the HCP during the clinic and if there were any changes in clinical outcomes (e.g. glucose control, weight, blood pressure, change in medication) using an anonymised version of routinely collected clinical data. Participants in this investigation are HCPs and there is no direct patient involvement.REC name
North of Scotland Research Ethics Committee 1
REC reference
23/NS/0134
Date of REC Opinion
4 Dec 2023
REC opinion
Favourable Opinion